Answers are grounded in this paper and cite their sources.
The δ1-protocadherins (δ1-PCDHs)-PCDH1, PCDH7, PCDH9, and PCDH11X/Y-are non-clustered cadherin superfamily proteins implicated in cell recognition and tissue-specific signaling. Although these proteins share seven extracellular cadherin repeats and conserved cytoplasmic motifs, evidence for their adhesive properties, molecular partners, and biological functions differs substantially among family members. PCDH1 has been investigated in airway epithelial homeostasis and TGF-β associated responses; PCDH7 in SET-PP2A related signaling, cancer progression, and osteoclast biology; PCDH9 in neuronal organization and tumor-associated signaling; and PCDH11X/Y in selected neural and cancer contexts. Disease associations range from genetic or expression correlations to functional perturbation studies, and should not be interpreted as equivalent evidence of causality. We critically review member-specific structure and function relationships, regulatory mechanisms, signaling pathways, and disease phenotypes, distinguishing directly demonstrated interactions from proposed models. We also assess emerging therapeutic concepts against their experimental support and outline a staged research strategy centered on isoform characterization, mechanistic validation, disease-relevant models, and biomarker evaluation. This evidence-based perspective identifies both the opportunities and limitations of considering δ1-PCDHs as adhesion-associated signaling regulators.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: